
Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Declines By 96.4%
Published on December 28, 2024
Fund Society FSB purchased a new position in VanEck Biotech ETF during the 3rd quarter valued at about $166,000. Institutional investors own
Other news
